Peptide histidine isoleucine‐like immunoreactivity release from the rat gastric fundus
Open Access
- 1 October 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (2) , 541-549
- https://doi.org/10.1111/j.1476-5381.1994.tb17023.x
Abstract
1 Longitudinal muscle strips from the rat gastric fundus were subjected to in vitro electrical field stimulation (EFS) under non-adrenergic non-cholinergic (NANC) conditions to study the release of peptide histidine isoleucine-like immunoreactivity (PHI-LI) and the correlation between PHI-LI release and NANC relaxation. 2 Different radioimmunoassay (RIA) systems employing C-terminal- and N-terminal-specific anti-PHI sera were used to determine the relative contributions of PHI and its C-terminally extended forms, peptide histidine glycine (PHI-Gly) and peptide histidine valine [PHV(1–42)], to the PHI-LI released by the rat gastric fundus. 3 In the presence of atropine (1 μm) and guanethidine (5 μm), EFS (120 mA, 1ms, 0.25–32.0 Hz, trains of 2 min) induced frequency-dependent relaxations of 5-hydroxytryptamine (3 μm) pre-contracted strips. 4 EFS at frequencies of 8–32 Hz evoked significant increases in PHI-LI outflow. The increases in PHI-LI outflow evoked by 16-Hz EFS were abolished by tetrodotoxin (3 μm) and by a calcium-free medium, indicating an active release process from intramural nerves. 5 The EFS-induced release of PHI-LI measured with the N-terminal-specific antiserum was significantly greater than that detected with the C-terminal-specific antisera. 6 Sephadex G-25 gel permeation chromatographic analysis was performed on the PHI-LI released in response to 32-Hz EFS. A C-terminal-specific antiserum revealed one peak co-eluting with the rat PHI standard. When PHI-LI was measured with the N-terminal-specific antiserum, two peaks were found that co-eluted with the rat PHV(1–42) and rat PHI-Gly/PHI standards, respectively. 7 The present data suggest that the extended forms of PHI are the primary components of the PHI-LI released by NANC inhibitory neurones in the rat gastric fundus and support a NANC inhibitory neurotransmitter role for PHI and its extended forms in this tissue.Keywords
This publication has 53 references indexed in Scilit:
- Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the rat gastric fundus: Role of endogenous nitric oxide and vasoactive intestinal polypeptideJournal of the Autonomic Nervous System, 1992
- Characterization of a novel prepro VIP derived peptideBiochemical and Biophysical Research Communications, 1986
- Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteriesBrain Research, 1984
- The distributions of PHI and VIP in porcine gut and their co-localisation to a proportion of intrinsic ganglion cellsPeptides, 1984
- Immunochemical study on PHI/PHM with use of synthetic peptidesPeptides, 1984
- Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cellsPeptides, 1984
- Prolactin-releasing activity of porcine intestinal peptide (PHI-27)Peptides, 1983
- Peptide histidine isoleucine (PHI)Digestive Diseases and Sciences, 1983
- Immunocytochemical demonstration of PHI and its co-existence with VIP in intestinal nerves of the rat and pig.Archivum histologicum japonicum, 1983
- Actions of a new peptide from porcine intestine (PHI) on pancreatic secretion in the rat and turkeyLife Sciences, 1980